Literature DB >> 21948451

Increasing αvβ3 selectivity of the anti-angiogenic drug cilengitide by N-methylation.

Carlos Mas-Moruno1, Johannes G Beck, Lucas Doedens, Andreas O Frank, Luciana Marinelli, Sandro Cosconati, Ettore Novellino, Horst Kessler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21948451     DOI： 10.1002/anie.201102971

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  8 in total

1.  Interface Immobilization Chemistry of cRGD-based Peptides Regulates Integrin Mediated Cell Adhesion.

Authors:  Diego Pallarola; Alexander Bochen; Heike Boehm; Florian Rechenmacher; Tariq R Sobahi; Joachim P Spatz; Horst Kessler
Journal:  Adv Funct Mater       Date:  2013-10-16       Impact factor: 18.808

2.  A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins.

Authors:  Tobias G Kapp; Florian Rechenmacher; Stefanie Neubauer; Oleg V Maltsev; Elisabetta A Cavalcanti-Adam; Revital Zarka; Ute Reuning; Johannes Notni; Hans-Jürgen Wester; Carlos Mas-Moruno; Joachim Spatz; Benjamin Geiger; Horst Kessler
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

3.  Novel Linear Peptides with High Affinity to αvβ3 Integrin for Precise Tumor Identification.

Authors:  Yi Ma; Guanhua Ai; Congying Zhang; Menglu Zhao; Xue Dong; Zhihao Han; Zhaohui Wang; Min Zhang; Yuxi Liu; Weidong Gao; Siwen Li; Yueqing Gu
Journal:  Theranostics       Date:  2017-04-06       Impact factor: 11.556

4.  Effectiveness of Direct Laser Interference Patterning and Peptide Immobilization on Endothelial Cell Migration for Cardio-Vascular Applications: An In Vitro Study.

Authors:  Romain Schieber; Carlos Mas-Moruno; Federico Lasserre; Joan Josep Roa; Maria-Pau Ginebra; Frank Mücklich; Marta Pegueroles
Journal:  Nanomaterials (Basel)       Date:  2022-04-05       Impact factor: 5.076

5.  Cu2+-Chelating Mesoporous Silica Nanoparticles for Synergistic Chemotherapy/Chemodynamic Therapy.

Authors:  Yanyan Zhang; Jiadong Lou; Gareth R Williams; Yuhan Ye; Dandan Ren; Anhua Shi; Junzi Wu; Wenling Chen; Li-Min Zhu
Journal:  Pharmaceutics       Date:  2022-06-04       Impact factor: 6.525

Review 6.  Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges.

Authors:  Xiao Hu; Yu-Sen Zhang; Yi-Chao Liu; Na Wang; Xian-Tao Zeng; Ling-Ling Zhang
Journal:  J Nanobiotechnology       Date:  2022-10-04       Impact factor: 9.429

7.  RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.

Authors:  Mark Sutherland; Andrew Gordon; Steven D Shnyder; Laurence H Patterson; Helen M Sheldrake
Journal:  Cancers (Basel)       Date:  2012-10-26       Impact factor: 6.639

Review 8.  Novel strategies for the treatment of chondrosarcomas: targeting integrins.

Authors:  Jui-Chieh Chen; Yi-Chin Fong; Chih-Hsin Tang
Journal:  Biomed Res Int       Date:  2013-12-30       Impact factor: 3.411
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.